Peter Graham
ORCID: 0000-0002-4957-4895
· 2 papers in corpus
The current biomarkers available in the clinic are not enough for early diagnosis or for monitoring disease progression of ovarian cancer. Liquid biopsy is a minimally invasive test and has the advantage of early diagnosis and real-time mon…
Uterine endometrialpolyp, hyperplasia and malignant transformation are well known side effects of Tamoxifen use in breast cancer patients. We present a case of hydronephrosis secondary to extra-uterine endometriosis in a female with mixed I…